What is the share price of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) today?

The share price of LOTUSEYE as on 11th July 2025 is ₹73.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

What is the return on Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?

The past returns of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share are Past 1 week: 4.20% Past 1 month: 0.83% Past 3 months: 13.29% Past 6 months: 11.63% Past 1 year: 23.90% Past 3 years: 37.18% Past 5 years: 131.17%

What are the peers or stocks similar to Lotus Eye Hospital and Institute Ltd (LOTUSEYE)?

The peers or stocks similar to Lotus Eye Hospital and Institute Ltd (LOTUSEYE) include: Lotus Eye Hospital and Institute Ltd Max Healthcare Institute Ltd Apollo Hospitals Enterprise Ltd Fortis Healthcare Ltd Narayana Hrudayalaya Ltd Global Health Ltd

What is the market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?

Market capitalization, short for market cap , is the market value of a publicly traded company's outstanding shares. The market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹151.92 Cr as of 11th July 2025.

What is the 52 week high and low of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?

The 52-week high of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹90.98 and the 52-week low is ₹54.99.

What is the PE and PB ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) stock?

The P/E (price-to-earnings) ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is 208.11. The P/B (price-to-book) ratio is 2.56.

Which sector does Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belong to?

Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

How to buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares?

You can directly buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Lotus Eye Hospital and Institute Ltd

LOTUSEYE Share Price

73.051.14% (-0.84)

Health Care

Hospitals & Diagnostic Centres

Smallcap

With a market cap of ₹151 cr, stock is ranked 2,726

High Risk

Stock is 3.51x as volatile as Nifty

LOTUSEYE Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care

Hospitals & Diagnostic Centres

Smallcap

With a market cap of ₹151 cr, stock is ranked 2,726

High Risk

Stock is 3.51x as volatile as Nifty

LOTUSEYE Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
213.97	2.56	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
36.68	6.41	0.79%

LOTUSEYE Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

LOTUSEYE Company Profile

Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.

LOTUSEYE Similar Stocks (Peers)

Compare with peers Compare with peers

LOTUSEYE Similar Stocks (Peers)

Compare with peers Compare with peers

Max Healthcare Institute Ltd

MAXHEALTH

PE Ratio

110.16

1Y Return

35.87%

Buy Reco %

75.00

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

PE Ratio

71.49

1Y Return

12.53%

Buy Reco %

89.66

Fortis Healthcare Ltd

FORTIS

PE Ratio

74.55

1Y Return

62.57%

Buy Reco %

92.86

Narayana Hrudayalaya Ltd

PE Ratio

51.59

1Y Return

62.55%

Buy Reco %

70.00

Global Health Ltd

MEDANTA

PE Ratio

72.76

1Y Return

4.53%

Buy Reco %

71.43

Compare with Peers

LOTUSEYE Forecast

LOTUSEYE Forecasts

LOTUSEYE

Income

Balance Sheet

Cash Flow

LOTUSEYE Income Statement

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	34.67	38.93	39.11	41.48	33.20	39.80	48.19	49.52	50.87	50.88
Raw Materials	10.27	10.89	6.18	6.11	4.76	5.69	6.93	7.05	46.13	46.14
Power & Fuel Cost	0.98	1.11	1.24	1.22	0.96	0.85	1.03	1.38
Employee Cost	7.00	7.78	8.49	8.17	6.82	6.98	8.52	9.25
Selling & Administrative Expenses	5.52	6.33	6.38	6.51	4.06	5.18	5.96	6.17
Operating & Other expenses	6.89	7.56	12.92	15.29	12.14	14.29	16.91	17.73
EBITDA	4.01	5.26	3.90	4.18	4.46	6.81	8.84	7.94	4.74	4.74
Depreciation/Amortization	3.44	3.37	3.06	2.50	2.33	2.50	2.98	3.73	3.01	3.02
PBIT	0.57	1.89	0.84	1.68	2.13	4.31	5.86	4.21	1.73	1.72
Interest & Other Items	0.15	0.18	0.21	0.24	0.14	0.21	0.20	0.20	0.36	0.36
PBT	0.42	1.71	0.63	1.44	1.99	4.10	5.66	4.01	1.37	1.36
Taxes & Other Items	-0.03	-0.04	-0.08	0.39	0.42	1.11	1.57	1.10	0.64	0.65
Net Income	0.45	1.75	0.71	1.05	1.57	2.99	4.09	2.91	0.73	0.71
EPS	0.22	0.84	0.34	0.50	0.75	1.44	1.97	1.40	0.36	0.34
DPS	0.50	0.50	0.00	0.00	0.50	0.50	0.50	0.00	0.00	0.00
Payout ratio	2.31	0.59	0.00	0.00	0.66	0.35	0.25	0.00	0.00	0.00

LOTUSEYE Income Statement

Quarter		dec 2022		mar 2023		jun 2023		sep 2023		dec 2023	mar 2024	jun 2024	sep 2024	dec 2024	mar 2025
Total Revenue	12.45	11.53	12.86	13.01	12.38	11.28	13.20	13.18	12.47	12.03
Operating & Other expenses	10.02	9.78	10.19	10.92	10.46	10.13	11.23	11.77	11.46	11.68
EBITDA	2.43	1.75	2.67	2.09	1.92	1.15	1.97	1.41	1.01	0.35
Depreciation/Amortization	0.77	0.78	0.73	0.89	0.98	1.12	1.06	1.23	1.31	-0.58
PBIT	1.66	0.97	1.94	1.20	0.94	0.03	0.91	0.18	-0.30	0.93
Interest & Other Items	0.02	0.02	0.02	0.01	0.04	0.03	0.06	0.08	0.13	0.09
PBT	1.64	0.95	1.92	1.19	0.90	-0.00	0.85	0.10	-0.43	0.84
Taxes & Other Items	0.49	0.30	0.54	0.34	0.24	-0.02	0.24	0.01	-0.19	0.59
Net Income	1.15	0.65	1.38	0.85	0.66	0.02	0.61	0.09	-0.24	0.25
EPS	0.56	0.31	0.67	0.41	0.32	0.01	0.30	0.05	-0.11	0.12

LOTUSEYE Cash Flow Statement

Financial Year		FY 2015		FY 2016		FY 2017		FY 2018		FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Cash from Operating Activities	2.37	3.38	2.97	5.78	4.20	4.97	2.73	4.41	4.39	5.68
Cash from Investing Activities	-4.65	-0.85	-1.06	-3.86	-4.01	-0.68	0.49	-3.94	-2.19	-4.63
Cash from Financing Activities	1.87	-0.58	-0.25	-1.51	-1.41	0.13	-0.32	-1.58	-1.71	-3.40
Net Change in Cash	-0.41	+1.95	+1.66	+0.41	-1.22	+4.42	+2.90	-1.11	+0.49	-2.35
Changes in Working Capital	-0.10	-0.86	-0.59	+0.84	+1.12	+1.00	-0.96	-1.60	-3.46	-1.22
Capital Expenditures	5.49	1.00	1.22	4.28	4.70	2.42	0.48	4.68	3.10	5.57
Free Cash Flow	-3.12	2.38	1.75	1.50	-0.50	2.55	2.25	-0.27	1.29	0.11

LOTUSEYE Company Updates

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

Investor Presentation

Jul 3PDF

FY 2021FY 2021

Annual report

PDF

Investor Presentation

Feb 9PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

FY 2015FY 2015

Annual report

PDF

LOTUSEYE Stock Peers

LOTUSEYE Past Performance & Peer Comparison

Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres

Valuation

Technical

Forecast

Compare valuation-basic on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Lotus Eye Hospital and Institute Ltd	208.11	2.56	—
Max Healthcare Institute Ltd	110.16	12.63	0.12%
Apollo Hospitals Enterprise Ltd	71.49	14.12	0.39%
Fortis Healthcare Ltd	74.55	6.75	0.13%

Stock	Buy Reco %Buy Reco %	Upside %Upside %	1Y Fwd EPS Grwth1Y Forward EPS Growth
Lotus Eye Hospital and Institute Ltd	Pro
Max Healthcare Institute Ltd
Apollo Hospitals Enterprise Ltd
Fortis Healthcare Ltd

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Lotus Eye Hospital and Institute Ltd	45.40%	64.03	Pro
Max Healthcare Institute Ltd	36.03%	56.87
Apollo Hospitals Enterprise Ltd	22.67%	56.98
Fortis Healthcare Ltd	33.58%	53.35

LOTUSEYE Stock Price Comparison

Compare LOTUSEYE with any stock or ETF

LOTUSEYE

LOTUSEYE Holdings

LOTUSEYE Shareholdings

LOTUSEYE Promoter Holdings Trend

LOTUSEYE Institutional Holdings Trend

LOTUSEYE Shareholding Pattern

LOTUSEYE Shareholding History

Foreign Institutions

LOTUSEYE Insider Trades & Bulk Stock Deals

smallcases containing LOTUSEYE stock

Looks like this stock is not in any smallcase yet.

LOTUSEYE Events

LOTUSEYE Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

LOTUSEYE Dividend Trend

No dividend trend available

LOTUSEYE Upcoming Dividends

No upcoming dividends are available

LOTUSEYE Past Dividends

Cash Dividend

Ex DateEx DateSep 18, 2023

Final

Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 18, 2023

Cash Dividend

Ex DateEx DateSep 8, 2022

Final

Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 8, 2022

Cash Dividend

Ex DateEx DateSep 8, 2021

Final

Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 8, 2021

Cash Dividend

Ex DateEx DateSep 14, 2018

Final

Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 14, 2018

Cash Dividend

Ex DateEx DateAug 2, 2017

Final

Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Aug 2, 2017

LOTUSEYE Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

LOTUSEYE Upcoming Announcements

No upcoming announcements are available

LOTUSEYE Past Announcements

Company Update

Announced OnJul 8, 2025

Lotus Eye Hospital And Institute Ltd - 5

Lotus Eye Hospital And Institute Ltd - 5 Download

Link

Download

Announced On

Jul 8, 2025

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Announced OnJul 8, 2025

Lotus Eye Hospital and Institute Limited

Lotus Eye Hospital and Institute Limited Download

Link

Download

Announced On

Jul 8, 2025

Clarification - Financial Results

Announced OnJul 1, 2025

The Exchange has sought clarification fr

Link

—

Announced On

Jul 1, 2025

Trading Window-XBRL

Announced OnJun 27, 2025

LOTUS EYE HOSPITAL AND INSTITUTE LIMITED

LOTUS EYE HOSPITAL AND INSTITUTE LIMITED Download

Link

Download

Announced On

Jun 27, 2025

Trading Window

Announced OnJun 27, 2025

Lotus Eye Hospital and Institute Limited

Lotus Eye Hospital and Institute Limited Download

Link

Download

Announced On

Jun 27, 2025

LOTUSEYE Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

LOTUSEYE Stock News & Opinions

Earnings

Lotus Eye Hospital & Institute standalone net profit rises 1150.00% in the March 2025 quarter

Net profit of Lotus Eye Hospital & Institute rose 1150.00% to Rs 0.25 crore in the quarter ended March 2025 as against Rs 0.02 crore during the previous quarter ended March 2024. Sales rose 5.79% to Rs 11.51 crore in the quarter ended March 2025 as against Rs 10.88 crore during the previous quarter ended March 2024. For the full year,net profit declined 74.57% to Rs 0.74 crore in the year ended March 2025 as against Rs 2.91 crore during the previous year ended March 2024. Sales rose 2.80% to Rs 49.56 crore in the year ended March 2025 as against Rs 48.21 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales11.5110.88 6 49.5648.21 3 OPM %-1.486.89 -6.9413.54 - PBDT0.251.12 -78 4.387.73 -43 PBT0.830 0 1.374.00 -66 NP0.250.02 1150 0.742.91 -75 Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

Lotus Eye Hospital & Institute to discuss results

Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live

Spotlight

Lotus Eye Hospital & Institute Ltd leads gainers in 'B' group

Country Condos Ltd, Hexa Tradex Ltd, Jagsonpal Pharmaceuticals Ltd and SEL Manufacturing Company Ltd are among the other gainers in the BSE's 'B' group today, 25 April 2025.Lotus Eye Hospital & Institute Ltd spiked 13.27% to Rs 76.75 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 22653 shares were traded on the counter so far as against the average daily volumes of 3096 shares in the past one month. Country Condos Ltd soared 9.92% to Rs 10.97. The stock was the second biggest gainer in 'B' group. On the BSE, 5.63 lakh shares were traded on the counter so far as against the average daily volumes of 1.25 lakh shares in the past one month. Hexa Tradex Ltd surged 6.95% to Rs 210.9. The stock was the third biggest gainer in 'B' group. On the BSE, 50 shares were traded on the counter so far as against the average daily volumes of 753 shares in the past one month. Jagsonpal Pharmaceuticals Ltd rose 6.69% to Rs 255.2. The stock was the fourth biggest gainer in 'B' group. On the BSE, 1.83 lakh shares were traded on the counter so far as against the average daily volumes of 9340 shares in the past one month. SEL Manufacturing Company Ltd exploded 4.98% to Rs 42.18. The stock was the fifth biggest gainer in 'B' group. On the BSE, 17410 shares were traded on the counter so far as against the average daily volumes of 6034 shares in the past one month. Powered by Capital Market - Live

2 months agoCapital Market - Live

Earnings

Lotus Eye Hospital & Institute reports standalone net loss of Rs 0.24 crore in the December 2024 quarter

Net loss of Lotus Eye Hospital & Institute reported to Rs 0.24 crore in the quarter ended December 2024 as against net profit of Rs 0.66 crore during the previous quarter ended December 2023. Sales rose 1.83% to Rs 12.25 crore in the quarter ended December 2024 as against Rs 12.03 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales12.2512.03 2 OPM %6.4513.13 - PBDT0.881.89 -53 PBT-0.430.91 PL NP-0.240.66 PL Powered by Capital Market - Live

4 months agoCapital Market - Live

Earnings

Lotus Eye Hospital & Institute standalone net profit declines 88.24% in the September 2024 quarter

Net profit of Lotus Eye Hospital & Institute declined 88.24% to Rs 0.10 crore in the quarter ended September 2024 as against Rs 0.85 crore during the previous quarter ended September 2023. Sales rose 1.41% to Rs 12.91 crore in the quarter ended September 2024 as against Rs 12.73 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.9112.73 1 OPM %8.9114.22 - PBDT1.342.07 -35 PBT0.111.18 -91 NP0.100.85 -88 Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Lotus Eye Hospital & Institute to discuss results

Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live

Earnings

Lotus Eye Hospital & Institute standalone net profit declines 55.07% in the June 2024 quarter

Net profit of Lotus Eye Hospital & Institute declined 55.07% to Rs 0.62 crore in the quarter ended June 2024 as against Rs 1.38 crore during the previous quarter ended June 2023. Sales rose 2.55% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 12.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8912.57 3 OPM %12.9618.93 - PBDT1.922.64 -27 PBT0.861.91 -55 NP0.621.38 -55 Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Lotus Eye Hospital & Institute to convene AGM

Lotus Eye Hospital & Institute announced that the 27th Annual General Meeting (AGM) of the company will be held on 13 August 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live

BRIEF-Lotus Eye Hospital And Institute - Names Kavetha Sundaramoorthy As Chairman - Investing.com India

4 years agoInvesting.com

BRIEF-Lotus Eye Hospital And Institute Ltd - Approved Appointment Of K.S. Ramalingam As CEO - Investing.com India

4 years agoInvesting.com

Frequently asked questions

What is the share price of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) today?
The share price of LOTUSEYE as on 11th July 2025 is ₹73.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?
The past returns of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share are
- Past 1 week: 4.20%
- Past 1 month: 0.83%
- Past 3 months: 13.29%
- Past 6 months: 11.63%
- Past 1 year: 23.90%
- Past 3 years: 37.18%
- Past 5 years: 131.17%
What are the peers or stocks similar to Lotus Eye Hospital and Institute Ltd (LOTUSEYE)?
The peers or stocks similar to Lotus Eye Hospital and Institute Ltd (LOTUSEYE) include:
What is the market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹151.92 Cr as of 11th July 2025.
What is the 52 week high and low of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?
The 52-week high of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹90.98 and the 52-week low is ₹54.99.
What is the PE and PB ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) stock?
The P/E (price-to-earnings) ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is 208.11. The P/B (price-to-book) ratio is 2.56.
Which sector does Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belong to?
Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.
How to buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares?
You can directly buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares on Tickertape. Simply sign up, connect your demat account and place your order.